The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study ; volume:41 ; number:12 ; day:12 ; month:8 ; year:2022 ; pages:3747-3752 ; date:12.2022
Clinical rheumatology ; 41, Heft 12 (12.8.2022), 3747-3752, 12.2022
- Urheber
-
Swart, I. A. P.
Visman, I. M.
Heslinga, M.
Horst-Bruinsma, I. E. van der
Denderen, J. C. van
Nurmohamed, M. T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-022-06330-9
- URN
-
urn:nbn:de:101:1-2023012522580086432482
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Swart, I. A. P.
- Visman, I. M.
- Heslinga, M.
- Horst-Bruinsma, I. E. van der
- Denderen, J. C. van
- Nurmohamed, M. T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Monitoring of anti-TNF biological treatments
Andersson lesion in ankylosing spondylitis
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
Stopping Anti-TNF in CD Remitters: Cons
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)